Attribution Statement: LactMed is a registered trademark of the U.S. Department of Health and Human Services.
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006-.
CASRN: 129497-78-5
Drug Levels and Effects
Summary of Use during Lactation
Limited information indicates that maternal verteporfin doses of 6 mg per square meter produce low levels in milk. Withholding breastfeeding for 24 to 48 hours after verteporfin administration should minimize risk to the breastfed infant.
Drug Levels
Maternal Levels. According to the manufacturer, verteporfin and its diacid metabolite were found in the breastmilk of one woman after a 6 mg per square meter IV infusion. The verteporfin levels in breastmilk were up to 66% of the corresponding plasma levels and became unmeasurable (<2 mcg/L) within 24 hours. The diacid metabolite had lower peak breastmilk concentrations, but persisted up to at least 48 hours.
Infant Levels. Relevant published information was not found as of the revision date.
Effects in Breastfed Infants
Relevant published information was not found as of the revision date.
Effects on Lactation and Breastmilk
Relevant published information was not found as of the revision date.
Substance Identification
Substance Name
Verteporfin
CAS Registry Number
129497-78-5
Drug Class
- Breast Feeding
- Porphyrins
- Photosensitizing Agents
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.
- User and Medical Advice Disclaimer
- Drugs and Lactation Database (LactMed) - Record Format
- LactMed - Database Creation and Peer Review Process
- Fact Sheet. Drugs and Lactation Database (LactMed)
- Drugs and Lactation Database (LactMed) - Glossary
- LactMed Selected References
- Drugs and Lactation Database (LactMed) - About Dietary Supplements
- Breastfeeding Links
- PubChem SubstanceRelated PubChem Substances
- Comparative skin phototoxicity in mice with two photosensitizing drugs: benzoporphyrin derivative monoacid ring A and porfimer sodium (Photofrin).[Fundam Appl Toxicol. 1995]Comparative skin phototoxicity in mice with two photosensitizing drugs: benzoporphyrin derivative monoacid ring A and porfimer sodium (Photofrin).Wolford ST, Novicki DL, Kelly B. Fundam Appl Toxicol. 1995 Jan; 24(1):52-6.
- Review Paclitaxel.[Drugs and Lactation Database (...]Review Paclitaxel.. Drugs and Lactation Database (LactMed®). 2006
- Review Iohexol.[Drugs and Lactation Database (...]Review Iohexol.. Drugs and Lactation Database (LactMed®). 2006
- Review Capecitabine.[Drugs and Lactation Database (...]Review Capecitabine.. Drugs and Lactation Database (LactMed®). 2006
- Review Riluzole.[Drugs and Lactation Database (...]Review Riluzole.. Drugs and Lactation Database (LactMed®). 2006
- Verteporfin - Drugs and Lactation Database (LactMed®)Verteporfin - Drugs and Lactation Database (LactMed®)
- Emu Oil - Drugs and Lactation Database (LactMed®)Emu Oil - Drugs and Lactation Database (LactMed®)
Your browsing activity is empty.
Activity recording is turned off.
See more...